NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹144.46
3.15%
NAV as on 03 Feb 26, 12:00 AM
risk
etf units
equity
NAV as on 03 Feb 26, 12:00 AM
risk
etf units
equity
3.31%p.a.
Last 1Y
22.88%p.a.
Last 3Y
0.00%p.a.
Last 5Y
12.23%p.a.
Since Inception
NRIs can achieve long-term capital appreciation by investing in the Axis NIFTY Healthcare ETF-Growth scheme from Axis Asset Management Company Ltd. It is a ETF Units mutual fund scheme that predominantly invests in ETF Units stocks of companies. Launched on Apr 2021, Axis NIFTY Healthcare ETF-Growth is ETF Units fund of its category with 20.14 Cr fund under management as on Feb 2026. The expense ratio of this fund is less than that of most other Fund category ETF Units funds.
The Investment Objective Of The Scheme Is To Provide Returns Before Expenses That Closelycorrespond To The Total Returns Of The Nifty Healthcare Index Subject To Tracking Errors.
Net Payables
-0.17%
Others CBLO
0.19%
Abbott India Ltd
1.54%
Apollo Hospitals Enterprise Ltd
7.38%
Aurobindo Pharma Ltd
3.37%
Biocon Ltd
2.41%
Zydus Lifesciences Ltd
2.33%
Cipla Ltd
8.66%
Divi's Laboratories Ltd
8.27%
Dr. Reddy's Laboratories Ltd
7.89%
View Scheme Document
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
If all details are correct, your KYC will be approved within 7 to 8 business days.
Funds
3Y Return

risk | open-ended
53.9%

risk | equity
37.7%

risk | equity
12.6%